1. Home
  2. TECH vs AES Comparison

TECH vs AES Comparison

Compare TECH & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • AES
  • Stock Information
  • Founded
  • TECH 1976
  • AES 1981
  • Country
  • TECH United States
  • AES United States
  • Employees
  • TECH N/A
  • AES N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • AES Electric Utilities: Central
  • Sector
  • TECH Health Care
  • AES Utilities
  • Exchange
  • TECH Nasdaq
  • AES Nasdaq
  • Market Cap
  • TECH 7.8B
  • AES 7.1B
  • IPO Year
  • TECH 1989
  • AES 1991
  • Fundamental
  • Price
  • TECH $49.15
  • AES $12.21
  • Analyst Decision
  • TECH Buy
  • AES Buy
  • Analyst Count
  • TECH 10
  • AES 7
  • Target Price
  • TECH $73.44
  • AES $12.86
  • AVG Volume (30 Days)
  • TECH 2.3M
  • AES 15.5M
  • Earning Date
  • TECH 05-07-2025
  • AES 05-01-2025
  • Dividend Yield
  • TECH 0.65%
  • AES 5.76%
  • EPS Growth
  • TECH N/A
  • AES 146.43
  • EPS
  • TECH 0.83
  • AES 1.83
  • Revenue
  • TECH $1,208,770,000.00
  • AES $12,119,000,000.00
  • Revenue This Year
  • TECH $8.19
  • AES $4.10
  • Revenue Next Year
  • TECH $8.61
  • AES $2.95
  • P/E Ratio
  • TECH $59.07
  • AES $6.69
  • Revenue Growth
  • TECH 4.72
  • AES N/A
  • 52 Week Low
  • TECH $46.44
  • AES $9.57
  • 52 Week High
  • TECH $85.57
  • AES $22.21
  • Technical
  • Relative Strength Index (RSI)
  • TECH 44.74
  • AES 65.04
  • Support Level
  • TECH $46.35
  • AES $10.19
  • Resistance Level
  • TECH $54.40
  • AES $12.67
  • Average True Range (ATR)
  • TECH 2.17
  • AES 0.42
  • MACD
  • TECH 0.27
  • AES 0.29
  • Stochastic Oscillator
  • TECH 34.78
  • AES 83.21

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: